Outcomes of Radiation Therapy Plus Immunotherapy in Metastatic Renal Cell Carcinoma: Results From the Canadian Kidney Cancer Information System

PURPOSE: With the integration of immunotherapy (IO) agents in the management of metastatic renal cell carcinoma (mRCC), there has been interest in the combined use with radiation therapy (RT). However, real world data are limited. The purpose of this study was to evaluate outcomes in patients with m...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Eric K., Lalani, Aly Khan A., Ghosh, Sunita, Basappa, Naveen S., Kapoor, Anil, Hansen, Aaron R., Kollmannsberger, Christian, Heng, Daniel, Wood, Lori A., Castonguay, Vincent, Soulières, Denis, Winquist, Eric, Canil, Christina, Graham, Jeffrey, Bjarnason, Georg A., Breau, Rodney H., Pouliot, Frédéric, Swaminath, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260099/
https://www.ncbi.nlm.nih.gov/pubmed/35814860
http://dx.doi.org/10.1016/j.adro.2022.100899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260099/
https://www.ncbi.nlm.nih.gov/pubmed/35814860
http://dx.doi.org/10.1016/j.adro.2022.100899

Ejemplares similares